SEC Form D · Amendment · filed February 13, 2023
Avilar Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (20)
Milind Deshpande · Cambridge, MADirectorDavid Neafus · Cambridge, MAExecTheresa Cameron · Boston, MADirectorPaulina Hill · Seattle, WADirectorMartin Freed · CHELSEA, MADirectorStephanie Tozzo · WALTHAM, MAExecPhil Graham · WALTHAM, MAExecDaniel Grau · Boston, MAExec · DirectorAdam Muzikant · WALTHAM, MAExecJoshua Resnick · Needham, MADirectorTheresa Cameron · Boston, MADirectorPaulina Hill · Seattle, WADirectorMartin Freed · Cambridge, MADirectorStephanie Tozzo · WALTHAM, MAExecPhil Graham · WALTHAM, MAExecMilind Deshpande · Cambridge, MADirectorDavid Neafus · Cambridge, MAExecDaniel Grau · Morrisville, NCExec · DirectorAdam Muzikant · WALTHAM, MAExecJoshua Resnick · Los Angeles, CADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗